Chemical Structure (Dexilant 01)
Dexilant Capsule, Delayed Release
Product Images NDC 64764-171
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexilant (NDC 64764-171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Dexilant 02)
This is a graph showing the plasma concentration in ng/mL over time (in hours) for two doses of DEXILANT (30mg and 60mg). The x-axis represents time from 0 to 24 hours in 4-hour intervals. The y-axis represents plasma concentration in ng/mL, ranging from 0 to 1200 ng/mL. The graph indicates that the plasma concentration of both doses of DEXILANT increases from 0 to peak shortly after 2 hours and then declines gradually over time.*
Principal Display Panel (30 mg Capsule Bottle Label)
This is a medication that comes in a bottle with 30 capsules, each containing 30mg of dexlansoprazole, an enteric-coated granule. The bottle should not be accepted if the seal over the opening is broken or missing. The usual dosage is indicated on the package insert. The medication is kept at room temperature and can be stored between 15-30°C. The medication is distributed by Takeda Pharmaceuticals and comes with a medication guide for each patient. The product's NDC code is 64764-171-30 and its GTIN code is 0364764171308.*
Principal Display Panel (60 mg Capsule Bottle Label)
This is a medication with NDC code 64764-175-30 containing 30 capsules each with 60 mg of dexlansoprazole as enteric-coated granules. It is a prescription-only drug that should not be accepted if the bottle opening seal is broken or missing. The dosage should be followed as per the package insert. It is manufactured and distributed by Takeda Pharmaceuticals America, Inc. The medication guide should be dispensed to the patient. The recommended storage temperature is 20 to 25°C (68 to 77°F) for delayed-release capsules. Inaccessible to non-English characters.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
